Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer
Authors
Keywords
-
Journal
International Journal of Nanomedicine
Volume Volume 15, Issue -, Pages 2323-2335
Publisher
Informa UK Limited
Online
2020-04-01
DOI
10.2147/ijn.s231214
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer
- (2019) Tong Liu et al. Molecular Cancer
- Role of HGF/c‐Met in the treatment of colorectal cancer with liver metastasis
- (2019) Jian‐feng Yao et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Engineering functional inorganic–organic hybrid systems: advances in siRNA therapeutics
- (2018) Jianliang Shen et al. CHEMICAL SOCIETY REVIEWS
- MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis
- (2018) Han S. Kim et al. JOURNAL OF SURGICAL ONCOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Overcoming Resistance to AC0010, a Third Generation of EGFR Inhibitor, by Targeting c-MET and BCL-2
- (2018) Wanhong Xu et al. NEOPLASIA
- Supramolecular cisplatin-vorinostat nanodrug for overcoming drug resistance in cancer synergistic therapy
- (2017) Shuting Xu et al. JOURNAL OF CONTROLLED RELEASE
- Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer
- (2017) Arman Jahangiri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis
- (2017) Haiyang Zhang et al. Nature Communications
- Unknown
- (2016) ADVANCED MATERIALS
- Mechanisms of Resistance to Chemotherapy in Gastric Cancer
- (2016) J.J.G. Marin et al. Anti-Cancer Agents in Medicinal Chemistry
- Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation
- (2016) Zhaogang Yang et al. JOURNAL OF CONTROLLED RELEASE
- PLK-1 Silencing in Bladder Cancer by siRNA Delivered With Exosomes
- (2016) Kristin A. Greco et al. UROLOGY
- Advanced gastric cancer: Current treatment landscape and future perspectives
- (2016) Antonia Digklia WORLD JOURNAL OF GASTROENTEROLOGY
- Exosomes in development, metastasis and drug resistance of breast cancer
- (2015) Dan-dan Yu et al. CANCER SCIENCE
- Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients
- (2015) Nozomu Fuse et al. Gastric Cancer
- Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance
- (2015) Ji Young Yhee et al. JOURNAL OF CONTROLLED RELEASE
- Knocking down disease: a progress report on siRNA therapeutics
- (2015) Anders Wittrup et al. NATURE REVIEWS GENETICS
- Treatment of gastric cancer
- (2014) Michele Orditura WORLD JOURNAL OF GASTROENTEROLOGY
- A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
- (2013) Yanhua Tian et al. BIOMATERIALS
- Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review
- (2013) Asfar S. Azmi et al. CANCER AND METASTASIS REVIEWS
- Exosomes are natural carriers of exogenous siRNA to human cells in vitro
- (2013) Tatyana A Shtam et al. Cell Communication and Signaling
- Active Wnt proteins are secreted on exosomes
- (2012) Julia Christina Gross et al. NATURE CELL BIOLOGY
- Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes
- (2012) Jessica Wahlgren et al. NUCLEIC ACIDS RESEARCH
- Current progress of siRNA/shRNA therapeutics in clinical trials
- (2011) John C. Burnett et al. Biotechnology Journal
- Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
- (2011) J. Jean Cui et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Microparticles
- (2010) Sebastian F. Mause et al. CIRCULATION RESEARCH
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation